Impact of quercetin on pharmacokinetics of quetiapine: insights from in-vivo studies in wistar rats

References

• Alnaqeeb M, Mansor KA, Mallah EM, et al. (2019). Critical pharmacokinetic and pharmacodynamic drug-herb interactions in rats between warfarin and pomegranate peel or guava leaves extracts. BMC Complement Altern Med 19:29.
   PubMed Web of Science ®Google Scholar
• Bhutani P, Rekha U, Shivakumar HN, et al. (2020). Rapid and cost-effective LC-MS/MS method for determination of hydroxycitric acid in plasma: application in the determination of pharmacokinetics in commercial Garcinia preparations. Biomed Chromatogr e4902.doi:10.1002/bmc.4902.
   PubMed Web of Science ®Google Scholar
• Brantley SJ, Argikar AA, Lin YS, et al. (2014). Herb-drug interactions: challenges and opportunities for improved predictions. Drug Metab Dispos 42:301–17.
   PubMed Web of Science ®Google Scholar
• Cameron IM, Hamilton RJ, Fernie G, MacGillivray SA. (2017). Obesity in individuals with schizophrenia: a case controlled study in Scotland. BJPsych Open 3:254–6.
   PubMed Web of Science ®Google Scholar
• Challa VR, Babu PR, Challa SR, et al. (2013). Pharmacokinetic interaction study between quercetin and valsartan in rats and in vitro models. Drug Dev Ind Pharm 39:865–72.
   PubMed Web of Science ®Google Scholar
• Cho HJ, Yoon IS. (2015). Pharmacokinetic interactions of herbs with cytochrome p450 and p-glycoprotein. Evid Based Complement Alternat Med 2015:736431.
   PubMed Web of Science ®Google Scholar
• Choi JS, Li X. (2005). Enhanced diltiazem bioavailability after oral administration of diltiazem with quercetin to rabbits. Int J Pharm 297:1–8.
   PubMedGoogle Scholar
• Choi JS, Piao YJ, Kang KW. (2011). Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin. Arch Pharm Res 34:607–13.
   PubMed Web of Science ®Google Scholar
• Choi MK, Song IS. (2019). Interactions of ginseng with therapeutic drugs. Arch Pharm Res 42:862–78.
   PubMed Web of Science ®Google Scholar
• Citrome L. (2017). Activating and sedating adverse effects of second-generation antipsychotics in the treatment of schizophrenia and major depressive disorder: absolute risk increase and number needed to harm. J Clin Psychopharmacol 37:138–47.
   PubMed Web of Science ®Google Scholar
• DeVane CL, Nemeroff CB. (2001). Clinical pharmacokinetics of quetiapine: an atypical antipsychotic. Clin Pharmacokinet 40:509–22.
   PubMed Web of Science ®Google Scholar
• Fagiolini A, Kupfer DJ, Houck PR, et al. (2003). Obesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatry 160:112–7.
   PubMed Web of Science ®Google Scholar
• Grimm SW, Richtand NM, Winter HR, et al. (2006). Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics. Br J Clin Pharmacol 61:58–69.
   PubMed Web of Science ®Google Scholar
• Gurley BJ. (2012). Pharmacokinetic herb-drug interactions (part 1): origins, mechanisms, and the impact of botanical dietary supplements. Planta Med 78:1478–89.
   PubMed Web of Science ®Google Scholar
• Han JH, Tian HZ, Lian YY, Yu Y, et al. (2015). Quetiapine mitigates the ethanol-induced oxidative stress in brain tissue, but not in the liver, of the rat. Neuropsychiatr Dis Treat 11:1473–82.
   PubMed Web of Science ®Google Scholar
• Hermann R, von Richter O. (2012). Clinical evidence of herbal drugs as perpetrators of pharmacokinetic drug interactions. Planta Med 78:1458–77.
   PubMed Web of Science ®Google Scholar
• Hughes RL. (2019). Fatal combination of mitragynine and quetiapine – a case report with discussion of a potential herb-drug interaction. Forensic Sci Med Pathol 15:110–3.
   PubMed Web of Science ®Google Scholar
• Jawahar N, Hingarh PK, Arun R, et al. (2018). Enhanced oral bioavailability of an antipsychotic drug through nanostructured lipid carriers. Int J Biol Macromol 110:269–75.
   PubMed Web of Science ®Google Scholar
• Limtrakul P, Khantamat O, Pintha K. (2005). Inhibition of P-glycoprotein function and expression by kaempferol and quercetin. J Chemother 17:86–95.
   PubMed Web of Science ®Google Scholar
• Luppino FS, de Wit LM, Bouvy PF, Stijnen T, et al. (2010). Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 67:220–9.
   PubMed Web of Science ®Google Scholar
• Mauri MC, Paletta S, Di Pace C, et al. (2018). Clinical pharmacokinetics of atypical antipsychotics: an update. Clin Pharmacokinet 57:1493–528.
   PubMed Web of Science ®Google Scholar
• McElroy SL. (2014). Pros and cons of approved therapies for bipolar depression and ongoing unmet needs. J Clin Psychiatry 75:e26.
   PubMedGoogle Scholar
• Moussa BA, Hashem HMA, Mahrouse MA, Tarek Mahmoud S. (2019). A validated RP-HPLC method for the evaluation of the influence of grapefruit juice on liver S9 activation of sacubitril. Biomed Chromatogr 33:e4553.
   PubMed Web of Science ®Google Scholar
• Muneer A. (2015). Pharmacotherapy of bipolar disorder with quetiapine: a recent literature review and an update. Clin Psychopharmacol Neurosci 13:25–35.
   PubMed Web of Science ®Google Scholar
• Obach RS. (1999). Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metab Dispos 27:1350–9.
   PubMed Web of Science ®Google Scholar
• Oga EF, Sekine S, Shitara Y, Horie T. (2016). Pharmacokinetic herb-drug interactions: insight into mechanisms and consequences. Eur J Drug Metab Pharmacokinet 41:93–108.
   PubMed Web of Science ®Google Scholar
• Pingili RB, Pawar AK, Challa SR. (2015). Systemic exposure of Paracetamol (acetaminophen) was enhanced by quercetin and chrysin co-administration in Wistar rats and in vitro model: risk of liver toxicity. Drug Dev Ind Pharm 41:1793–800.
   PubMed Web of Science ®Google Scholar
• Ravindran AV, Al-Subaie A, Abraham G. (2010). Quetiapine: novel uses in the treatment of depressive and anxiety disorders. Expert Opin Investig Drugs 19:1187–204.
   PubMed Web of Science ®Google Scholar
• Samalin L, Tremey A, Llorca PM. (2014). Quetiapine extended release for the treatment of bipolar disorder. Expert Rev Neurother 14:987–1005.
   PubMed Web of Science ®Google Scholar
• Schmitt U, Kirschbaum KM, Poller B, et al. (2012). In vitro P-glycoprotein efflux inhibition by atypical antipsychotics is in vivo nicely reflected by pharmacodynamic but less by pharmacokinetic changes. Pharmacol Biochem Behav 102:312–20.
   PubMed Web of Science ®Google Scholar
• Shaik YB, Castellani ML, Perrella A, et al. (2006). Role of quercetin (a natural herbal compound) in allergy and inflammation. J Biol Regul Homeost Agents 20:47–52.
   PubMed Web of Science ®Google Scholar
• Shrivastava A, Johnston ME. (2010). Weight-gain in psychiatric treatment: risks, implications, and strategies for prevention and management. Mens Sana Monogr 8:53–68.
   PubMedGoogle Scholar
• Silverstone T, Smith G, Goodall E. (1988). Prevalence of obesity in patients receiving depot antipsychotics. Br J Psychiatry 153:214–7.
   PubMed Web of Science ®Google Scholar
• Upadhyay P, Trivedi J, Pundarikakshudu K, Sheth N. (2016). Comparative study between simple and optimized liposomal dispersion of quetiapine fumarate for diffusion through nasal route. Drug Deliv 23:1214–21.
   PubMed Web of Science ®Google Scholar
• Ventura S, Rodrigues M, Falcao A, Alves G. (2019). Short-term effects of Garcinia cambogia extract on the pharmacokinetics of lamotrigine given as a single-dose in Wistar rats. Food Chem Toxicol 128:61–7.
   PubMed Web of Science ®Google Scholar
• Vermeer LM, Isringhausen CD, Ogilvie BW, Buckley DB. (2016). Evaluation of ketoconazole and its alternative clinical CYP3A4/5 inhibitors as inhibitors of drug transporters: the in vitro effects of ketoconazole, ritonavir, clarithromycin, and itraconazole on 13 clinically-relevant drug transporters. Drug Metab Dispos 44:453–9.
   PubMed Web of Science ®Google Scholar
• Vijayakumar TM, Kumar RM, Agrawal A, et al. (2015). Comparative inhibitory potential of selected dietary bioactive polyphenols, phytosterols on CYP3A4 and CYP2D6 with fluorometric high-throughput screening. J Food Sci Technol 52:4537–43.
   PubMed Web of Science ®Google Scholar
• Wu X, Ma J, Ye Y, Lin G. (2016). Transporter modulation by Chinese herbal medicines and its mediated pharmacokinetic herb-drug interactions. J Chromatogr B Analyt Technol Biomed Life Sci 1026:236–53.
   PubMed Web of Science ®Google Scholar
• Xu H, Chen Z, He J, et al. (2006). Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus. Hippocampus 16:551–9.
   PubMed Web of Science ®Google Scholar
• Yang X, Poddar I, Hernandez CM, et al. (2015). Simultaneous quantitation of quetiapine and its active metabolite norquetiapine in rat plasma and brain tissue by high performance liquid chromatography/electrospray ionization tandem mass spectrometry (LC-MS/MS). J Chromatogr B Analyt Technol Biomed Life Sci 1002:71–7.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Wei J, Zhang H. (2019). Effects of quercetin on the pharmacokinetics of losartan and its metabolite EXP3174 in rats. Xenobiotica 49:563–8.
   PubMed Web of Science ®Google Scholar
• Zhou D, Bui KH, Li J, Al-Huniti N. (2015). Population pharmacokinetic modeling of quetiapine after administration of seroquel and seroquel XR formulations to Western and Chinese patients with schizophrenia, schizoaffective disorder, or bipolar disorder. J Clin Pharmacol 55:1248–55.
   PubMed Web of Science ®Google Scholar